Corporate
Vanda Pharma's NEREUS Becomes First New Motion Sickness Drug in 40 Years — Shares Surge 18%
Dec 31, 2025
You're signed outSign in or to get full access.
Vanda Pharmaceuticals (VNDA) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Vanda Pharmaceuticals.
Q3 2025
Oct 29, 2025
Q2 2025
Jul 31, 2025
Q1 2025
May 7, 2025
Q4 2024
Feb 13, 2025
Q3 2024
Nov 6, 2024
Q2 2024
Jul 31, 2024
Q1 2024
May 8, 2024